Allied Supreme Corp

Allied Supreme Corp maintains a strong liquidity position, with a current ratio of 4.64 and cash and equivalents of TWD 1.57 billion, which is well above the median for its industry. The company’s debt-to-equity ratio of 0.06 indicates a conservative capital structure, with long-term debt accounting for only TWD 483 million against total equity of TWD 8.23 billion. Profitability metrics show the company is performing well relative to its industry. Return on equity (ROE) of 9.91% and return on assets (ROA) of 7.88% are both above the median for specialty chemicals firms, indicating efficient use of equity and assets to generate returns. Operating income of TWD 1.00 billion and net income of TWD 816 million reflect strong margins, with gross profit of TWD 1.56 billion supporting this performance. The company’s revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided. This suggests a high degree of exposure to the performance of its core chemical products and potentially to regional demand fluctuations. Looking ahead, Allied Supreme Corp is projected to maintain stable revenue growth, with no significant changes expected in the near term. Free cash flow was negative at TWD -135 million in the latest period, primarily due to capital expenditures of TWD -188 million, which may indicate ongoing investment in production capacity or maintenance. Risk factors for the company are currently low, with no immediate liquidity or dilution concerns identified. The company has not issued any recent equity, and there are no signs of near-term dilution pressure. However, the negative free cash flow and capital expenditures suggest that the company may need to manage its cash flow carefully in the coming periods. Recent filings and transcripts do not indicate any material events or strategic shifts. Analysts have provided a mean price target of TWD 370, with a median and high target also at TWD 370, suggesting a consensus view of stable performance. The mean recommendation of 1.80 (on a 1–5 scale) reflects a generally positive outlook, with two strong-buy and two buy ratings.